blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1893228

EP1893228 - CHIMERIC POLYPEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION [Right-click to bookmark this link]
Former [2008/10]CHIMERICPOLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
[2015/44]
StatusNo opposition filed within time limit
Status updated on  27.01.2017
Database last updated on 05.10.2024
Most recent event   Tooltip06.07.2018Lapse of the patent in a contracting state
New state(s): LU		published on 08.08.2018  [2018/32]
Applicant(s)For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel Ange
75794 Paris Cedex 16 / FR
[N/P]
Former [2016/12]For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75794 Paris Cedex 16 / FR
Former [2008/10]For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75794 Paris Cedex 16 / FR
Inventor(s)01 / TANGY, Frédéric
60, rue Garde Chasse
93260 Les Lilas / FR
02 / LUCAS-HOURANI, Marianne
38, rue des Epinettes
75017 Paris / FR
03 / NAVARRO-SANCHEZ, Erika
62, rue Joseph Gaillard
93100 Montreuil-sous-Bois / FR
04 / FRENKIEL, Marie-Pascale
15, rue Chaptal
92300 Levallois-Perret / FR
05 / BEDOUELLE, Hugues
4 rue Auguste Bartholdi
75015 Paris / FR
06 / COMBREDET, Chantal
124 Avenue de Villiers
75017 Paris / FR
07 / DESPRES, Philippe
18 Place de la Liberté
92250 La Garenne-Colombes / FR
 [2016/12]
Former [2008/10]01 / TANGY, Frédéric
60, rue Garde Chasse
F-93260 Les Lilas / FR
02 / LUCAS-HOURANI, Marianne
38, rue des Epinettes
F-75017 Paris / FR
03 / NAVARRO-SANCHEZ, Erika
62, rue Joseph Gaillard
F-93100 Montreuil-sous-Bois / FR
04 / FRENKIEL, Marie-Pascale
15, rue Chaptal
F-92300 Levallois-Perret / FR
05 / BEDOUELLE, Hugues
4 rue Auguste Bartholdi
F-75015 PARIS / FR
06 / COMBREDET, Chantal
124 Avenue de Villiers
F-75017 Paris / FR
07 / DESPRES, Philippe
18 Place de la Liberté
F-92250 La Garenne-Colombes / FR
Representative(s)Desaix, Anne, et al
Ernest Gutmann - Yves Plasseraud S.A.S.
66, rue de la Chaussée d'Antin
75009 Paris / FR
[N/P]
Former [2008/10]Desaix, Anne, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber
75009 Paris / FR
Application number, filing date06778626.920.06.2006
[2008/10]
WO2006FR01396
Priority number, dateCA2005250826620.06.2005         Original published format: CA 2508266
[2008/10]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2006136697
Date:28.12.2006
Language:FR
[2006/52]
Type: A2 Application without search report 
No.:EP1893228
Date:05.03.2008
Language:FR
The application published by WIPO in one of the EPO official languages on 28.12.2006 takes the place of the publication of the European patent application.
[2008/10]
Type: B1 Patent specification 
No.:EP1893228
Date:23.03.2016
Language:FR
[2016/12]
Search report(s)International search report - published on:EP08.03.2007
ClassificationIPC:A61K38/16, C07K14/18, C12N15/09, C12N15/62, C12N15/86, C07K16/10
[2008/10]
CPC:
C07K14/005 (EP,US); A61K39/12 (EP,US); A61K39/165 (US);
A61P31/12 (EP); A61P31/14 (EP); A61P37/04 (EP);
C12N15/86 (EP,US); C12N7/00 (US); A61K2039/5254 (EP,US);
A61K2039/5256 (EP,US); A61K2039/53 (EP,US); A61K2039/545 (EP,US);
A61K2039/55 (EP,US); A61K2039/55505 (EP,US); A61K38/00 (EP,US);
C07K2319/00 (EP,US); C07K2319/04 (EP,US); C12N2760/18434 (US);
C12N2760/18443 (EP,US); C12N2770/24122 (EP,US); C12N2770/24134 (EP,US);
C12N2770/24171 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/12]
Former [2008/10]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:CHIMÄRISCHE POLYPEPTIDE UND IHRE THERAPEUTISCHE VERWENDUNG GEGEN FLAVIVIRIDAE-INFEKTIONEN[2008/10]
English:CHIMERIC POLYPEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION[2015/44]
French:POLYPEPTIDES CHIMERIQUES ET LEURS APPLICATIONS THÉRAPEUTIQUES CONTRE UNE INFECTION À FLAVIVIRIDAE[2008/10]
Former [2008/10]CHIMERICPOLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase30.11.2007National basic fee paid 
30.11.2007Designation fee(s) paid 
30.11.2007Examination fee paid 
Examination procedure30.11.2007Examination requested  [2008/10]
17.12.2009Despatch of a communication from the examining division (Time limit: M06)
25.06.2010Reply to a communication from the examining division
07.12.2012Despatch of a communication from the examining division (Time limit: M04)
11.04.2013Reply to a communication from the examining division
27.03.2015Despatch of a communication from the examining division (Time limit: M04)
04.08.2015Reply to a communication from the examining division
20.10.2015Communication of intention to grant the patent
04.12.2015Fee for grant paid
04.12.2015Fee for publishing/printing paid
26.01.2016Information about intention to grant a patent
26.01.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.12.2009
Opposition(s)02.01.2017No opposition filed within time limit [2017/09]
Fees paidRenewal fee
16.05.2008Renewal fee patent year 03
15.05.2009Renewal fee patent year 04
17.05.2010Renewal fee patent year 05
18.05.2011Renewal fee patent year 06
21.05.2012Renewal fee patent year 07
23.05.2013Renewal fee patent year 08
20.05.2014Renewal fee patent year 09
22.05.2015Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.06.2006
CY23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
PL23.03.2016
RO23.03.2016
SI23.03.2016
SK23.03.2016
IE20.06.2016
LU20.06.2016
BG23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
[2018/29]
Former [2018/28]HU20.06.2006
CY23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
PL23.03.2016
RO23.03.2016
SI23.03.2016
SK23.03.2016
IE20.06.2016
BG23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/37]CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
PL23.03.2016
RO23.03.2016
SI23.03.2016
SK23.03.2016
IE20.06.2016
BG23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/20]CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
PL23.03.2016
RO23.03.2016
SK23.03.2016
BG23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/07]CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
PL23.03.2016
RO23.03.2016
SK23.03.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/51]CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
PL23.03.2016
RO23.03.2016
SK23.03.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/50]CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
PL23.03.2016
RO23.03.2016
SK23.03.2016
GR24.06.2016
IS23.07.2016
Former [2016/49]EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
PL23.03.2016
GR24.06.2016
IS23.07.2016
Former [2016/48]FI23.03.2016
LT23.03.2016
LV23.03.2016
GR24.06.2016
IS23.07.2016
Former [2016/39]FI23.03.2016
LT23.03.2016
LV23.03.2016
GR24.06.2016
Former [2016/36]FI23.03.2016
LT23.03.2016
GR24.06.2016
Former [2016/35]FI23.03.2016
GR24.06.2016
Cited inInternational search[A]WO0196376  (PASTEUR INSTITUT [FR], et al);
 [X]WO2004076619  (PASTEUR INSTITUT [FR], et al) [X] 1-20 * the whole document *;
 [PA]WO2005111221  (PASTEUR INSTITUT [FR], et al);
 [A]  - CATTEAU ADELINE ET AL, "Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM.", JOURNAL OF GENERAL VIROLOGY, (200310), vol. 84, no. 10, ISSN 0022-1317, pages 2781 - 2793, XP002405613

DOI:   http://dx.doi.org/10.1099/vir.0.19163-0
 [A]  - CATTEAU ADELINE ET AL, "Expression of dengue ApoptoM sequence results in disruption of mitochondrial potential and caspase activation.", BIOCHIMIE (PARIS), (200308), vol. 85, no. 8, ISSN 0300-9084, pages 789 - 793, XP002405614

DOI:   http://dx.doi.org/10.1016/S0300-9084(03)00139-1
 [A]  - COLOMBAGE G ET AL, "DNA-Based and Alphavirus-Vectored Immunisation with PrM and E Proteins Elicits Long-Lived and Protective Immunity against the Flavivirus, Murray Valley Encephalitis Virus", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, (19981010), vol. 250, no. 1, ISSN 0042-6822, pages 151 - 163, XP004445627

DOI:   http://dx.doi.org/10.1006/viro.1998.9357
 [A]  - FONSECA B A L ET AL, "RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEINS PRM AND E INDUCE NEUTRALIZING ANTIBODIES IN MICE", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (1994), vol. 12, no. 3, ISSN 0264-410X, pages 279 - 285, XP009018695

DOI:   http://dx.doi.org/10.1016/0264-410X(94)90206-2
 [A]  - CRILL W D ET AL, "Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein arethe most efficient blockers of virus adsorption to Vero cells", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200108), vol. 75, no. 16, ISSN 0022-538X, pages 7769 - 7773, XP002982315

DOI:   http://dx.doi.org/10.1128/JVI.75.16.7769-7773.2001
 [A]  - DESPRÈS P ET AL, "Live measles vaccine expressing the secreted form of the west nile virus envelope glycoprotein protects against west nile virus encephalitis", JOURNAL OF INFECTIOUS DISEASES 15 JAN 2005 UNITED STATES, (20050115), vol. 191, no. 2, ISSN 0022-1899, pages 207 - 214, XP009074536

DOI:   http://dx.doi.org/10.1086/426824
 [A]  - MOTA J ET AL, "Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20050516), vol. 23, no. 26, ISSN 0264-410X, pages 3469 - 3476, XP004852137

DOI:   http://dx.doi.org/10.1016/j.vaccine.2004.12.028
 [A]  - WANG SONGLI ET AL, "PrM- and cell-binding domains of the dengue virus E protein", JOURNAL OF VIROLOGY, (199903), vol. 73, no. 3, ISSN 0022-538X, pages 2547 - 2551, XP002405616
 [PA]  - HERMIDA ET AL, "A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20060412), vol. 24, no. 16, ISSN 0264-410X, pages 3165 - 3171, XP005344486 [PA] * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2006.01.036
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.